Figure 4

Relationships between plasma PAI-1 and Ang II changes induced by candesartan in hypertensive patients with metabolic syndrome. ^*P<0.05 vs. baseline; ^**P<0.01 vs. baseline; °P<0.05 vs. imidapril; ⁺P<0.01 vs. imidapril. Ang II, angiotensin II; PAI-1, plasminogen activator inhibitor.